Manzo Louis 4

Accession 0001104659-20-022104

CIK 0001133869other

View on SEC.gov Company Profile

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 6:08 PM ET

Size

35.7 KB

Accession

0001104659-20-022104

Insider Transaction Report

Form 4

Period: 2020-02-12

CAPRICOR THERAPEUTICS, INC.CAPR

Manzo Louis

Director

Transactions

Award
Stock Option (Right to Buy)
2020-02-12+4,500→ 4,500 total
Exercise: $1.39Exp: 2029-08-08→ Common Stock (4,500 underlying)
Award
Stock Option (Right to Buy)
2020-02-12+2,550→ 2,550 total
Exercise: $1.39Exp: 2028-01-02→ Common Stock (2,550 underlying)
Award
Stock Option (Right to Buy)
2020-02-12+2,356→ 2,356 total
Exercise: $1.39Exp: 2027-01-03→ Common Stock (2,356 underlying)
Award
Stock Option (Right to Buy)
2020-02-12+3,000→ 3,000 total
Exercise: $1.39Exp: 2026-06-02→ Common Stock (3,000 underlying)
Award
Stock Option (Right to Buy)
2020-02-12+1,500→ 1,500 total
Exercise: $1.39Exp: 2025-03-03→ Common Stock (1,500 underlying)
Award
Stock Option (Right to Buy)
2020-02-12+1,401→ 1,401 total
Exercise: $1.39Exp: 2023-03-06→ Common Stock (1,401 underlying)
Award
Stock Option (Right to Buy)
2020-02-12+27,904→ 27,904 total
Exercise: $1.39Exp: 2022-04-27→ Common Stock (27,904 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2020-02-12−4,500→ 0 total
Exercise: $3.25Exp: 2029-08-08→ Common Stock (4,500 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2020-02-12−2,550→ 0 total
Exercise: $15.70Exp: 2028-01-02→ Common Stock (2,550 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2020-02-12−2,356→ 0 total
Exercise: $25.50Exp: 2027-01-03→ Common Stock (2,356 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2020-02-12−3,000→ 0 total
Exercise: $31.20Exp: 2026-06-02→ Common Stock (3,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2020-02-12−1,500→ 0 total
Exercise: $57.80Exp: 2025-03-03→ Common Stock (1,500 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2020-02-12−1,401→ 0 total
Exercise: $3.70Exp: 2023-03-06→ Common Stock (1,401 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2020-02-12−27,904→ 0 total
Exercise: $3.70Exp: 2022-04-27→ Common Stock (27,904 underlying)

Footnotes (5)

[F1]3,000 of the shares were vested on the date of grant. The remaining 1,500 shares will vest 1/48th on the first day of each month, commencing September 1, 2019, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting.
[F2]The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options, with a new exercise price of $1.39 per share.
[F3]1,050 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2018, until the stock option becomes fully vested and exercisable. The remaining 1,500 shares will vest 1/12th on the first day of each month, commencing February 1, 2018, with the last month vesting on December 31, 2018. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting.
[F4]856 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2017, until the stock option becomes fully vested and exercisable. The remaining 1,500 shares will vest 1/12th on the first day of each month, commencing February 1, 2017, with the last month vesting on December 31, 2017. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting.
[F5]The stock option award is fully vested and exercisable.

Documents

1 file

4
tm208086d7_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CAPRICOR THERAPEUTICS, INC.

CIK 0001133869

→

Entity typeother

Related Parties

filerCIK 0001593100

Filing Metadata

Form type: 4
Filed: Feb 13, 7:00 PM ET
Accepted: Feb 14, 6:08 PM ET
Size: 35.7 KB

View on SEC.gov